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Summary
Centrosomes in mammalian cells have recently been
implicated in cytokinesis; however, their role in this
process is poorly defined. Here, we describe a human
coiled-coil protein, Cep55 (centrosome protein 55
kDa), that localizes to the mother centriole during in-
terphase. Despite its association with -TuRC anchor-
ing proteins CG-NAP and Kendrin, Cep55 is not re-
quired for microtubule nucleation. Upon mitotic entry,
centrosome dissociation of Cep55 is triggered by
Erk2/Cdk1-dependent phosphorylation at S425 and
S428. Furthermore, Cep55 locates to the midbody and
plays a role in cytokinesis, as its depletion by siRNA
results in failure of this process. S425/428 phosphor-
ylation is required for interaction with Plk1, enabling
phosphorylation of Cep55 at S436. Cells expressing
phosphorylation-deficient mutant forms of Cep55 un-*Correspondence: kumkumK@qimr.edu.au
8 Lab address: http://www.qimr.edu.audergo cytokinesis failure. These results highlight the
centrosome as a site to organize phosphorylation of
Cep55, enabling it to relocate to the midbody to func-
tion in mitotic exit and cytokinesis.
Introduction
The centrosome is the principle microtubule organizing
center of the mammalian cell, consisting of a pair of
barrel-shaped microtubule assemblies which are non-
identical and are described as the mother and daughter
centrioles (Nigg, 2002). They (mainly the mother) are
surrounded by pericentriolar material (PCM), which con-
sists of a matrix of predominantly coiled-coil proteins.
PCM is the main site for nucleation of cytoplasmic
microtubules and microtubules to form the meiotic and
mitotic spindles. The centrosome is structurally and
functionally regulated in a cell cycle-dependent manner
to form a bipolar spindle to ensure the proper segrega-
tion of replicated chromosomes into two daughter cells
(Blagden and Glover, 2003). Defects in the number,
structure, and function of centrosomes can generate
mono- or multipolar mitotic spindles and cytokinesis
defects resulting in aneuploidy and chromosome insta-
bility, which are common characteristics of tumor cells.
Therefore, it is not surprising that these centrosome ab-
normalities are frequently found in tumors and are usu-
ally associated with high cytological grade (Pihan et al.,
2003). Thus, it is critical to understand regulators of the
centrosome cycle because it must be carefully coordi-
nated with the cell cycle to complete cell division pre-
cisely.
Microtubule nucleation by the PCM requires the con-
served complex, γ-tubulin ring complex (γ-TuRC), in meta-
zoan organisms (Schiebel, 2000). In yeast, the large
coiled-coil spindle pole body (SPB) protein Spc110p an-
chors γ-tubulin ring complex, providing sites for micro-
tubule nucleation. In mammalian cells, Kendrin, like its
yeast homolog Spc110p (Flory et al., 2000), complexes
with CG-NAP to provide a structural scaffold for γ-TuRC
(Takahashi et al., 2002). Nlp has also been implicated in
γ-TuRC anchorage (Casenghi et al., 2003). CG-NAP and
Kendrin associate with several protein kinases and
phosphatases (Diviani et al., 2000; Takahashi et al.,
1999, 2000), suggesting that microtubule nucleation
may be regulated through phosphorylation of CG-NAP/
Kendrin complexes or associated proteins which re-
main to be defined.
In recent years, several studies have provided a link
between centrosomes and cytokinesis. Acentrosomal
cells have been shown to form mitotic spindles and
progress through mitosis but fail to complete cytokine-
sis (Hinchcliffe et al., 2001; Khodjakov and Rieder, 2001).
The molecular understanding of centrosome function in
cytokinesis is only beginning to emerge. During cytoki-
nesis, the mother centriole has been shown to tran-
siently reposition to the midbody correlating with bridge
narrowing and microtubule depolymerization, while
movement away from the midbody correlates with cell
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478cleavage (Piel et al., 2001). It is proposed that the
mother centriole regulates an as yet unidentified path-
way anchored at the centrosome that is analogous to
the mitotic exit pathways in budding yeast called the
“mitotic exit network,” which is anchored at the SPB
and controls mitotic exit and cytokinesis (McCollum
and Gould, 2001). The siRNA silencing of a recently
identified mother centriole component, centriolin, pro-
duces cytokinesis failure (Gromley et al., 2003), suggest-
ing that it is a component of this pathway in mammalian
cells. However, additional components and pathways
that control cytokinesis will need to be identified to
understand the precise role of centrosomes in this
process.
Here, we report the molecular characterization of a
coiled-coil protein called Cep55. Cep55 localizes to the
centrosome of interphase cells and to the midbody dur-
ing cytokinesis. Characterization of Cep55-depleted
cells reveals that Cep55 participates in membrane ab-
scission to form two daughter cells. Furthermore, Cdk1,
Erk2, and Plk1 cooperate in the mitotic phosphorylation
of Cep55, and this modification is required for its cor-
rect mitotic localization and cytokinesis function to
maintain genomic stability.
Results
Identification of a Mother Centriole- and Midbody-
Associated Protein, Cep55
Using a bioinformatics screen (see Supplemental Data),
we identified a protein, encoded by EST FLJ10540, re-
ferred to as Cep55 (centrosome protein 55 kDa). Cep55
encodes a cDNA that is transcribed from chromosome
10q23.33, consisting of nine exons, of which exon 1 is
noncoding. This cDNA encodes a protein of 464 amino
acids with three centrally located coiled-coil domains
(residues 57–355; Figure 1A), a motif found in several
centrosome proteins. BLAST analysis revealed that this
protein shares 21% identity/39% similarity with the
yeast SPB proteins Nuf1 in Saccharomyces cerevisiae
and Spc110p in Schizosaccharomyces pombe. Beyond
these matches, however, only weak similarity with other
coiled-coil proteins could be identified. Northern blot
analysis revealed that Cep55 is highly expressed in tes-
tis and thymus (Figure 1B).
The putative yeast homologs of Cep55, Nuf1, and
Spc110p locate to the yeast SPB (Kilmartin et al., 1993;
Mirzayan et al., 1992). Therefore, we investigated whether
Cep55 could locate to the centrosome (equivalent or-
ganelle to SPB in mammals) by assessing the localiza-
tion of green fluorescent protein (GFP)-tagged Cep55
in mammalian cells. GFP-Cep55 localized to centro-
somes as demonstrated by its colocalization with the
centriole marker GT335, which recognizes polygluta-
mylated tubulin (Figure 1C). Interestingly, GFP-Cep55
appeared to preferentially localize to one of the two
GT335 centriole spots, suggesting that Cep55 may
preferentially associate with one of the two centrioles.
This staining is reminiscent of centriolin (Gromley et al.,
2003) and ninein (Mogensen et al., 2000), whereby
electron microscopy has localized these proteins to the
mother centriole. Colocalization of GFP-Cep55 with
centriolin indicated that Cep55 is a mother centriole
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trotein (Figure 1D). In addition, microscopy analysis re-
ealed that only a small portion of GFP-Cep55 localized
o the mother centriole, whereas the majority localized
o the PCM (Figure 1C, lower panel). Endogenous
ep55 was also shown to localize to the centrosome
y using anti-Cep55 antibodies as indicated by its colo-
alization with γ-tubulin (Figure 1E). Furthermore, cen-
rosome localization of endogenous Cep55 was shown
o be independent of microtubules because it remained
ssociated with the centrosome when microtubules
ere depolymerized (Figure 1E). The centrosome local-
zation of both endogenous and GFP-Cep55 was con-
irmed in other cells lines, MCF-7 and 293T (data not
hown). Consistent with this, proteome analysis iden-
ified Cep55 in crude centrosome preparations from hu-
an lymphoblastic KE-37 cells (Andersen et al., 2003).
In contrast to most centrosome proteins, such as
-tubulin, which are recruited to the centrosome late in
2 to prepare for microtubule nucleation (Blagden and
lover, 2003), a detailed analysis of Cep55 localization
evealed that Cep55 loses affinity for the centrosome at
he onset of prophase and diffuses throughout the cell,
oinciding with centrosome separation and chromatin
ondensation (Figure 1F). This lack of centrosome
taining during mitosis is unlikely to be due to epitope
asking, as similar observations were made in cells
xpressing Flag-Cep55 and GFP-Cep55. Furthermore,
uring anaphase and telophase, GFP-Cep55 diffusely
abels the midzone and then concentrates at the mid-
ody during cytokinesis (Figure 1F, lower panel). En-
ogenous Cep55 was also observed at the midbody
Figure 1F). These findings indicate that Cep55 local-
zes to the mother centriole of interphase cells and is
ecruited to the midbody during cytokinesis.
ocalization of Cep55 to the Centrosome
nd Midbody Is Mediated by Its C-Terminus
o assess the region of Cep55 that is important for tar-
eting it to the centrosome and midbody of cells, we
ransiently expressed GFP-Cep55 deletion proteins in
2OS cells that lacked regions either N-terminal (57–
64) or C-terminal (1–355) to the coiled-coil domains,
r both (57–355) (Figure 2A). Like wild-type GFP-Cep55,
he N-terminal deletion mutant, 57–464, localized to the
nterphase centrosome and to the midbody of U2OS
ells (Figure 2B). In contrast, GFP-Cep55 proteins
–355 and 57–355, which lacked the C-terminal resi-
ues 355–464, lost the ability to locate to these intracel-
ular domains (Figure 2B), indicating that residues 355–
64 target Cep55 to the centrosome and midbody.
ndeed, analysis of ectopically expressed GFP-Cep55
355–464) in U2OS cells demonstrated that this is the
ase (Figure 2B). Similar results were obtained in HeLa
nd 293T cells (data not shown), indicating that the
-terminal residues 355–464 target Cep55 to the in-
erphase centrosome and to the midbody of cells un-
ergoing cytokinesis.
ep55 Is Phosphorylated on the C-Terminal
esidues S425 and S428 upon Mitotic Entry
e next tested whether the changes in localization of
ep55 during mitosis are caused by its phosphoryla-
ion. HeLa cells were synchronized at G , S phase, G ,1 2
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479Figure 1. Cep55 Is a Coiled-Coil Protein that Localizes to the Mother Centriole and the Midbody
(A) Schematic representation of Cep55 indicating the location of the coiled-coil domains.
(B) Expression of Cep55 in the indicated tissues was assessed by Northern blotting.
(C) Representative microscopy images of HeLa cells transfected with GFP-Cep55 costained with antibodies directed against the centriole
marker GT335 (red). In the lower panel, an enlargement of the merged image is displayed demonstrating that GFP-Cep55 localizes to the
PCM of centrosomes.
(D) HeLa cells coimmunostained with anti-centriolin (green) and GT335 (red) antibodies illustrate that centriolin preferentially localizes to the
mother centriole (upper panels), as previously described (Gromley et al., 2003). A representative U2OS cell illustrating colocalization of GFP-
Cep55 and centriolin antibody (red) at the mother centriole is shown (lower panels).
(E) U2OS cells were immunostained with anti-Cep55 and anti-γ-tubulin antibodies before and after depolymerization of microtubules by
incubation on ice for 30 min.
(F) Asynchronously growing HeLa cells were stained for endogenous Cep55 (green) and α-tubulin (red). Representative cells from different
stages of the cell cycle are shown. Midzone/midbody localization of GFP-Cep55 ectopically expressed in HeLa cells is shown below. DNA is
shown in blue.and M phase by a double-thymidine release assay and,
interestingly, Cep55 was detected as a doublet in mi-
totic cells compared to interphase cells (Figure 3A). The
slower migrating Cep55 form was confirmed to be mi-tosis specific, as it was predominant in HeLa cells that
had been synchronized in prometaphase of mitosis by
treatment with the microtubule depolymerizing drug
nocodazole (Figure 3B). Lambda phosphatase (λ-PPase)
Developmental Cell
480Figure 2. The C-Terminal Residues, 355–464, Target Cep55 to the
Centrosome and Midbody
(A) Schematic representation of full-length Cep55 and the indicated
Cep55 deletion mutants. A summary of the ability of these Cep55
proteins to localize to the centrosome and midbody is shown.
(B) Representative microscopy images of the centrosome and mid-
body localization of the GFP-Cep55 mutants described in (A) in
U2OS cells. γ-tubulin is shown in red.
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mtreatment of mitotic lysates caused Cep55 to shift to
the faster migrating form, indicating that this mitosis-
specific form is phosphorylated (Figure 3C). Further-
more, treatment of asynchronous cells with the serine/
threonine phosphatase inhibitor okadaic acid caused
Cep55 to shift to the slower migrating form, mimicking
mitotic phosphorylation (Figure 3C). These findings
provide evidence that Cep55 is phosphorylated speci-
fically during mitosis.
To define the region and specific residues of Cep55
that are phosphorylated during mitosis, Flag-Cep55
full-length and deletion mutants were assessed for their
phosphorylation status following nocodazole treatment.
Mitotic phosphorylation of Flag-Cep55 was not af-
fected in the protein that lacked the N-terminus, 57–
464 (Figure 3D). In contrast, the Flag-Cep55 proteins
(1–355 and 57–355), which lacked the C-terminus (355–
464), were not phosphorylated following nocodazole
treatment, suggesting that Cep55 is phosphorylated on
a residue(s) located within 355–464 during mitosis.
Consistent with these data, Flag-Cep55(1–355) did not
incorporate 32P-orthophosphate compared to full-
length Flag-Cep55 in an in vivo labeling experiment
(Figure 3E). Phosphoamino acid analysis of Flag-Cep55
revealed that it is phosphorylated exclusively on serine
residues during mitosis (data not shown), and se-
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tuence analysis of Cep55 residues 355–464 identified
our serine residues which could be phosphorylated
ased on their conservation between human, mouse,
nd rat (Figure 3F). These four sites were S396, S425,
428, and S436 and each was systematically mutated
o alanine in Flag-Cep55 to generate four mutant con-
tructs. Mutation of S425 and S428 to alanine partially
educed Flag-Cep55 phosphorylation in mitotic cells (Fig-
re 3G), whereas S396 and S436 had no effect (data not
hown). Mutagenesis of both sites (S425/428A) com-
letely abolished Flag-Cep55 phosphorylation (Figure
G) and incorporation of 32P-orthophosphate into Flag-
ep55 during mitosis (Figure 3E). These residues were
onfirmed to be in vivo phosphorylation sites by mass
pectrometry (see Supplemental Data). Mass spec-
rometry also identified S436 as an in vivo phosphoryla-
ion site and strongly suggested that there is a hierar-
hy of phosphorylation, where both S425 and S428 are
hosphorylated prior to S436 phosphorylation to pro-
uce three in vivo phosphorylation sites on Cep55.
ep55 Residues S425 and S428 Are Phosphorylated
y Erk2 and Cdk1 upon Mitotic Entry
he Cep55 mitosis-specific phosphorylation sites, S425
nd S428, are followed by a proline at the 1+ position.
wo serine/proline-directed kinases implicated in mi-
otic regulation are Cdk1 and Erk2, suggesting that
ep55 may be a substrate of one or both of these ki-
ases. Overexpression of constitutively active forms of
dk1 (AF) and/or Erk2 (LA), but not their kinase dead
orms, caused a phosphorylation-induced mobility shift
n Flag-Cep55 (Figure 4A). However, overexpression of
dk1-AF did not retard the mobility of the entire pool
f Flag-Cep55 (Figure 4A). In contrast, constitutively
ctive Erk2 and Cdk1 were not able to shift the phos-
horylation mutant S425/428A (Figure 4B). The involve-
ent of Cdk1 and Erk2 were confirmed by using their
pecific inhibitors, roscovitine and U0126, respectively,
s both inhibitors impaired the nocodazole-induced
hosphorylation of Cep55 (Figure 4C). However, it is im-
ortant to note that the Erk2 inhibitor was better than
he Cdk inhibitor in blocking phosphorylation of Cep55
Figure 4C). Next, we asked whether Erk2 and/or Cdk1
hosphorylate S425 and S428 directly in vitro. Indeed,
inase assays demonstrated Cep55 is a substrate of
oth kinases; however, Cdk1/cyclin B1 was inefficient
t mediating the phosphorylation of Cep55 compared
o the autophosphorylation of cyclin B1. In contrast,
ndetectable/minimal phosphorylation of the double
utant S425/428A was observed (Figures 4D and 4E),
ndicating that both kinases can mediate phosphoryla-
ion of Cep55 at the same sites.
hosphorylation of Cep55 at S425/428 Enhances
lk1 Binding and Phosphorylation at S436
ecent studies have suggested that proline-directed
inases, such as Cdk1 and Erk2, cooperate with the
olo-like kinase (Plk1) to phosphorylate several pro-
eins, including Cdc25C (Elia et al., 2003) and cyclin B1
Yuan et al., 2002). The polo-box domain of Plk1 is a
hosphopeptide binding motif that binds phosphoryla-
ion sites generated by Cdk1 and Erk2, enabling Plk1
o mediate the phosphorylation of the target protein at
Cep55 Is Required for Cytokinesis
481Figure 3. Cep55 Is Phosphorylated during Mitosis at S425 and S428
(A) Immunoblot analysis of Cep55 in HeLa cells synchronized at the
indicated cell cycle phases.
(B) Cell lysates (30 g) from asynchronous and mitotic cells (noco-
dazole-treated) were immunoblotted with an anti-Cep55 antibody.
(C) Lysates were prepared as described in (B) and treated with
λ-PPase. Cellular lysates were also prepared from HeLa cells
treated with the phosphatase inhibitor okadaic acid. Lysates (30
g) were immunoblotted with an anti-Cep55 antibody.
(D) Schematic illustration of wild-type Cep55 and the indicated
Cep55 deletion mutants. A summary of the phosphorylation status
of these Flag-Cep55 proteins during mitosis is shown (upper
panel). The indicated Flag-Cep55 deletion mutants were trans-
fected into HeLa cells and assessed for their phosphorylation
status, indicated by a mobility shift, following nocodazole treat-
ment by immunoblotting lysates (30 g) with an anti-Flag antibody
(lower panel).
(E) Labeling of Flag vector, pFlag-Cep55, pFlag-Cep55-S425/428A,
and pFlag-Cep55 (1–355) with 32P in mitotic HEK293 cells. Autora-gressed through mitosis (Figure 4J), indicating that
diography and immunoblot of the Flag-Cep55 proteins are shown
in the upper and lower panels, respectively.
(F) Comparison of the C-terminal sequence of Cep55 orthologs.
Conserved residues are indicated with asterisks and the two mito-
sis-specific phosphorylation sites, S425 and S428, are underlined.
(G) Lysates from asynchronous and nocodazole-treated HeLa cells
ectopically expressing wild-type or the indicated pFlag-Cep55
phosphomutant were immunoblotted with an anti-Flag antibody.
S425/428A mutation completely abolishes Flag-Cep55 nocoda-
zole-induced mobility shift.additional sites (Barr et al., 2004). Several lines of evi-
dence suggest that Cep55 is phosphorylated by these
kinases in this manner: (1) Cep55 is phosphorylated at
S436, which is a Plk1 consensus site and (2) S436 phos-
phorylation requires prior phosphorylation at S425/428 by
Cdk1/Erk2 (see Supplemental Data). Consistent with
our hypothesis, overexpression of Plk1, but not another
mitotic kinase, Aurora A caused a phosphorylation-
induced mobility shift of wild-type Flag-Cep55, analo-
gous to nocodazole treatment (Figure 4F). In contrast,
Plk1 was not able to mediate the phosphorylation of
Flag-Cep55-S425/428A (Figure 4F), suggesting that
Plk1-dependent phosphorylation of Cep55 requires
prior phosphorylation at S425 and S428 by Erk2 and/or
Cdk1. Next, we asked whether Cep55 interacts with
Plk1 and whether this interaction occurs in a phosphor-
ylation-dependent manner. Remarkably, wild-type but
not the phosphorylation mutant form (S425/428A) of
Flag-Cep55 coimmunoprecipitates with wild-type Myc-
Plk1 when coexpressed in HeLa cells (Figure 4G), again
suggesting that the association requires Cep55 phos-
phorylation. Furthermore, we could detect an associa-
tion between endogenous Plk1 and the phosphorylated
form of Cep55 in mitotic cells, but not in asynchronous
cells, by coimmunoprecipitation experiments (Figure
4H), indicating that this interaction occurs under physi-
ological conditions. We next asked whether Plk1 can
directly phosphorylate Cep55 at S436. In vitro Plk1 ki-
nase assays illustrated that Cep55 is a Plk1 substrate
and mutagenesis of S436 to alanine revealed that Plk1
specifically phosphorylates this residue, but not an-
other site within the C-terminus of Cep55, which con-
forms to the Plk1 consensus, S396 (Figure 4I). Taken
together, we provide evidence that Cdk1, Erk2, and
Plk1 cooperate to phosphorylate Cep55 during mitosis.
Mutation of Cep55 Phosphorylation Sites S425
and S428 Prevents Its Dissociation
from the Centrosome at the G2/M Boundary
Cep55 loses affinity for the centrosome at the onset of
mitosis (Figure 1) and this correlates with its phosphor-
ylation (Figure 3), suggesting that phosphorylation of
Cep55 may induce its centrosome dissociation at the
G2/M boundary. Both wild-type Flag-Cep55 and the
Plk1-dependent phosphorylation mutant, Flag-Cep55-
S436A, did not label the mitotic centrosomes, but dif-
fusely labeled the cytoplasm (Figure 4J), indicating that
phosphorylation at S436 is not responsible for mediat-
ing Cep55 centrosome dissociation upon mitotic entry.
In contrast, the phosphorylation mutant, S425/428A, re-
mained associated with the centrosome as cells pro-
Developmental Cell
482Figure 4. Cdk1/Cyclin B1, Erk2, and Plk1 Kinases Contribute to Cep55 Mitotic Phosphorylation
(A) 293T cells were transfected with pFlag-Cep55 alone or in combination with constitutively active Erk2 (LA) or Cdk1 (AF) or with kinase
dead Erk2 (KR) or Cdk1 (DN). At 48 hr posttransfection, lysates were prepared and immunoblotted with anti-Flag, anti-Myc, and anti-Cdk1 anti-
bodies.
(B) Lysates prepared from 293T cells ectopically expressing wild-type and phosphomutant (S425/428A) Flag-Cep55 either alone or with Erk2-
LA or Cdk1-AF were immunoblotted with anti-Flag, anti-Myc, and anti-Cdk1 antibodies.
(C) HeLa cells were treated with the Cdk1 inhibitor roscovitine, or the Erk2 inhibitor U0126, or in combination with nocodazole as described
in Experimental Procedures. Lysates were immunoblotted with anti-Cep55 antibodies.
(D) In vitro Cdk1/cyclin B1 kinase assay. Bacterially produced recombinant Cdk1/cyclin B1 kinase was incubated with the indicated GST-
Cep55 protein in a kinase buffer containing 32P-ATP. Phosphorylated proteins were detected by autoradiography.
(E) In vitro Erk2 kinase assay. Lysates from HeLa cells ectopically expressing kinase dead (KR) or constitutively active (LA) Myc-Erk2 were
immunoprecipitated with an anti-Myc antibody and then incubated with the indicated GST-Cep55 protein in kinase buffer containing 32P-ATP.
Phosphorylated proteins were detected by autoradiography.
(F) Lysates prepared from 293T cells ectopically expressing wild-type and phosphomutant (S425/428A) Flag-Cep55 either alone or with Myc-
Plk1 or Flag-Aurora A were immunoblotted with anti-Flag antibodies.
(G) HeLa cells were transfected with Myc-Plk1 and Flag vector or the indicated Flag-Cep55 construct. Prepared lysates were immunoprecipi-
tated with an anti-Flag antibody and then immunoblotted with anti-Myc or anti-Flag antibodies.
(H) Lysates prepared from asynchronous and mitotic HeLa cells were immunoprecipitated with either a nonspecific IgG or anti-Plk1 antibody
and then immunoblotted with anti-Cep55 and anti-Plk1 antibodies.
(I) In vitro Plk1 kinase assay. Lysates prepared from HeLa cells ectopically expressing wild-type or kinase dead Myc-Plk1 (K82R) were
immunoprecipitated with an anti-Myc antibody and then incubated with the indicated GST-Cep55 protein in kinase buffer containing 32P-ATP.
Phosphorylated proteins were detected by autoradiography.
(J) HeLa cells ectopically expressing wild-type or phosphorylation mutant forms of Flag-Cep55 were costained with anti-Cep55 and anti-γ-
tubulin antibodies. Immunofluorescence microscopy of cells in metaphase illustrates that unlike wild-type Flag-Cep55 and the Plk1-depen-
dent phosphorylation mutant S436A, the Erk2/Cdk1-dependent phosphorylation site mutant S425/428A labels the centrosome during meta-
phase as indicated by its colocalization with γ-tubulin.
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483phosphorylation at S425 and S428 is required for its
dissociation from the centrosome at the G2/M boundary.
Cep55 Associates with the Centrosome Proteins
CG-NAP and Kendrin, but Is Not Required
for Microtubule Nucleation
To assign Cep55 a function, we assessed the ability of
Cep55 to associate with the centrosome proteins CG-
NAP and Kendrin, which are involved in microtubule nu-
cleation in mammalian cells (Takahashi et al., 2002), the
best characterized function of centrosomes. GFP-
Cep55 coimmunoprecipitated with Flag-CG-NAP and
HA-Kendrin in asynchronous Cos-7 cells (Figures 5A
and 5B). In contrast, consistent with our data indicating
that Cep55 dissociates from the centrosome upon mi-
totic entry, GFP-Cep55 did not coimmunoprecipitate
with Flag-CG-NAP or HA-Kendrin in mitotic cells (Fig-
ures 5A and 5B). We investigated this association fur-
ther by defining the region of CG-NAP and Cep55 that
interacts with the other. Coimmunoprecipitation experi-
ments revealed that these proteins associate via their
C-termini (Figures 5C and 5D), which interestingly is theFigure 5. Cep55 Complexes with the Centro-
some Proteins CG-NAP and Kendrin, but Is
Not Required for Microtubule Nucleation
(A and B) Lysates from asynchronous and mi-
totic Cos-7 cells ectopically expressing either
(A) GFP-Cep55 and Flag-CG-NAP or (B) GFP-
Cep55 and HA-Kendrin were immunoprecipi-
tated with an anti-CG-NAP antibody or an
anti-Kendrin antibody, respectively, and then
immunoblotted with anti-GFP antibody.
(C) GFP-Cep55 and the indicated Flag-CG-
NAP deletion mutants were coexpressed in
Cos-7 cells. Prepared lysates were immuno-
precipitated with an anti-Flag antibody and
then immunoblotted with an anti-GFP an-
tibody.
(D) Cos-7 cells were transfected with either
full-length GFP-Cep55 or GFP-Cep55(355–
464) and Flag-CG-NAP(2875–3899). Pre-
pared lysates were immunoprecipitated with
an anti-Flag antibody and then immunoblot-
ted with an anti-GFP antibody.
(E) Immunofluorescence microscopy of
Cep55-stained HeLa cells transfected with
the indicated siRNA demonstrates that
Cep55 expression is depleted by its specific
siRNA and not by the control (GFP siRNA).
These cells were also stained for γ-tubulin,
CG-NAP, and Kendrin to analyze their cen-
trosome localization.
(F) U2OS cells were transfected with GFP or
Cep55 siRNA and subjected to an in vivo
microtubule nucleation assay at 72 hr post-
transfection. Microtubules were visualized
with α-tubulin.centrosome targeting domain of each protein (Figure 2;
Takahashi et al., 2002).
We next investigated whether Cep55 is required for
microtubule nucleation because it complexes with CG-
NAP and Kendrin. Although this interaction dissociates
and Cep55 disappears from the centrosome upon mi-
totic entry, suggesting that Cep55 might not participate
directly in this function, the centrosome displacement,
however, of other proteins such as Nlp have been
shown to be required for microtubule nucleation by al-
lowing the establishment of a mitotic scaffold in order
to enhance microtubule nucleation activity (Casenghi
et al., 2003). To analyze the requirement of Cep55 for
microtubule nucleation, we utilized siRNA technology
to deplete Cep55 from cells. Importantly, at 72 hr post-
transfection, Cep55 siRNA specifically depleted Cep55
expression by >90%, whereas the GFP siRNA control
had no effect (Figure 5E; and shown by Western blot-
ting; Figure 6A). Immunofluorescence microscopy also
revealed that Cep55 depletion does not affect centro-
some localization of γ-tubulin and the γ-TuRC anchoring
proteins CG-NAP and Kendrin (Figure 5E). By using an
in vivo microtubule regrowth assay to assess microtu-
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(A) Immunoblot of Cep55 in GFP siRNA and Cep55 siRNA transfected HeLa cells at 48, 72, and 96 hr posttransfection. γ-tubulin expression
was used as a loading control.
(B and C) At the indicated times following transfection, GFP and Cep55 siRNA transfected cells were immunostained with anti-α-tubulin
antibodies. Per sample >200 cells were scored for the presence of R2 nuclei/cell (multinucleation; [B]) or for cells that were arrested at the
midbody stage (C).
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(D) Representative images of GFP and Cep55 siRNA transfected cells from the data described in (B) and (C) at 72 hr posttransfection.
α-tubulin is shown in red. DNA is shown in blue.
(E) The number of mitotic cells with multipolar spindles was compared in Cep55-depleted cells to control cells at 72 hr posttransfection by
immunostaining for γ-tubulin. The graph illustrates mean ±SD from two independent experiments. More than 50 mitotic cells were scored
per sample.
(F) Representative images of the data described in (E). γ-tubulin is shown in red. DNA is shown in blue.
(G) Representative time-lapse images of a control cell proceeding through mitosis is shown (upper panel). In the lower panels, representative
time-lapse images of Cep55-depleted cells with either one or two nuclei proceeding through mitosis are shown.
(H) Graph of time-lapse microscopy data shows the percentage of GFP (n = 287) and Cep55 siRNA (n = 167) transfected cells that proceeded
through mitosis but failed to cleave, resulting in multinucleation.
(I) Graph illustrates the average time taken for GFP (n = 63) and Cep55 siRNA (n = 38) transfected HeLa cells to proceed from prophase to
cell cleavage and prophase to cell cleavage failure, respectively.
the successful completion of cytokinesis in mammalianbule nucleation, we demonstrate that Cep55 is not re-
quired for microtubule nucleation, because microtubule
asters were visible upon regrowth to the same extent
in Cep55-depleted cells as in control cells (GFP siRNA;
Figure 5F).
siRNA-Mediated Depletion of Cep55 Induces Cellular
Phenotypes Consistent with Cytokinesis Failure
To assign a function to Cep55, we sought to character-
ize the cellular phenotype of Cep55-depleted cells
using siRNA. At all time points analyzed after transfec-
tion (48, 72, and 96 hr), Cep55 expression was reduced
markedly by Cep55 siRNA, but not by GFP siRNA (Fig-
ure 6A). Immunofluorescence microscopy analysis re-
vealed that depletion of Cep55 produces phenotypes
consistent with cytokinesis failure, that is, multinucle-
ated cells (Figures 6B and 6D) and cells arrested at the
midbody stage (late telophase; Figures 6C and 6D). Im-
portantly, no significant cytokinesis defects were ob-
served in control cells. Moreover, an increasing number
of Cep55-depleted cells showed cytokinesis defects
with time. Aberrant mitotic spindles (>2 mitotic spindle
poles) were also frequently observed during metaphase
of cells depleted of Cep55 (57%), compared to control
cells (10%) (Figures 6E and 6F). These were not the
result of loss of centriole cohesion or hyperamplifica-
tion of centrosomes in Cep55-depleted cells (data not
shown); instead, this defect arises as a consequence of
cytokinesis failure, as most Cep55-depleted cells with
multipolar spindles were aneuploid (i.e., binucleate).
To thoroughly characterize the mechanism of cytoki-
nesis failure, we subjected live HeLa cells transfected
with Cep55 siRNA to time-lapse microscopy analysis
for 18 hr beginning at 30 hr posttransfection (see Mov-
ies S1–S3). The majority of control cells (GFP siRNA)
that entered mitosis carried out normal cell cleavage to
form two daughter cells with normal kinetics (2 hr 25
min ± 6 min; Figure 6G). Cep55-depleted cells also pro-
gressed through mitosis from prophase to telophase
with normal kinetics; however, the majority of Cep55-
depleted cells failed to complete cytokinesis (57.8% ±
20.1%; Figures 6G and 6H). Consistent with observa-
tions of fixed cells, these live cells remained in a post-
telophase position, connected by a thin cytoplasmic
bridge for a prolonged period of time, increasing their
mitotic period by up to 7 hr prior to regression of the
cleavage furrow, resulting in a binucleate cell (Figures
6G and 6I). These binucleate cells did not have difficulty
entering the next cell division, but again failed to cleavenuclei/cell; Figure 6G). Again, consistent with our ob-
servations of fixed cells, only binucleate cells produced
multipolar spindles during metaphase (Figure 6G), indi-
cating that this phenotype is a result of cytokinesis fail-
ure. These observations collectively indicate that
Cep55 is not required for normal mitotic progression
but is essential for successful completion of cytoki-
nesis.
Ectopic Expression of the Cep55 Phosphorylation
Mutants, S425/428A and S436A, Induces
Cytokinesis Failure
Several lines of evidence have implicated Plk1 in the
regulation of cytokinesis (Mundt et al., 1997). In this re-
port, we demonstrate that Cep55 associates with and
is phosphorylated by Plk1 during mitosis and that
Cep55 itself is required for the completion of cytokine-
sis, suggesting that these proteins may cooperate to
regulate this final stage of cell division. In support of
this idea, we demonstrate that endogenous Cep55 and
Plk1 colocalize at the midbody during cytokinesis (Fig-
ure 7A). We next aimed to understand the relationship
between Plk1-dependent phosphorylation of Cep55
and function. In contrast to untransfected control cells
(<5%), two or more nuclei were observed in >15% of
HeLa cells expressing ectopic Flag-Cep55 and in
w30% of HeLa cells ectopically expressing either of
the Flag-Cep55 phosphorylation mutants S425/428A or
S436A (Figures 7B and 7C). Furthermore, a significant
proportion of cells expressing Flag-Cep55-S425/428A
or Flag-Cep55-S436A were arrested at the midbody
stage compared to control cells (Figures 7B and 7C).
Immunofluorescence microscopy revealed that muta-
genesis of these phosphorylation sites does not affect
targeting of Cep55 to this intracellular domain (Figure
7C), ruling out the possibility that these cytokinesis de-
fects are due to an indirect effect caused by mislocal-
ization. Thus, we demonstrate that Cep55 phosphoryla-
tion at S425, S428, and S436 is required for its function
during the final stages of cell division to complete cyto-
kinesis successfully.
Discussion
The molecular mechanisms of cytokinesis in animal
cells are less well known compared to yeast cell divi-
sion, particularly the signaling pathways that result in
and regulate mitotic exit and cytokinesis. In this study,
we have identified a protein, Cep55, that is required for
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phorylation Mutants Causes Cytokinesis
Failure
(A) Representative immunofluorescence mi-
croscopy images of HeLa cells costained
with anti-Cep55 and anti-Plk1 antibodies il-
lustrating midbody colocalization.
(B) At 72 hr posttransfection, HeLa cells ec-
topically expressing wild-type Flag-Cep55 or
the Flag-Cep55 phosphorylation mutants
S425/428 and S436A were costained with
anti-Cep55 and anti-α-tubulin antibodies.
Transfected cells were scored for the indi-
cated cytokinesis defects. The graph shows
the mean percentage of cells with these cy-
tokinesis defects ±SD from two indepen-
dent experiments.
(C) Representative images of the data shown
in (B).cells as cell membrane abscission fails in cells depleted
of Cep55. Interestingly, the cytokinesis defects pro-
duced by depletion of Cep55 are identical to the pheno-
types produced by acentrosomal cells (Hinchcliffe et
al., 2001; Khodjakov and Rieder, 2001). We also demon-
strate that Cep55 is a centrosome protein and thus our
data further enhance the importance of centrosomes in
the final stages of cell division. Interestingly, we illustrate
that Cep55 does not remain associated with the centro-
some during mitosis, and its displacement from the
centrosome is triggered by its phosphorylation. There-
fore, we propose a model whereby the centrosome acts
as a regulatory site to organize phosphorylation of
Cep55 upon mitotic entry. This phosphorylated Cep55
is then able to locate to the midbody during the final
stages of cell division to function in the signal transduc-
tion pathway(s) that results in mitotic exit and cytokine-
sis. Therefore, we propose that dephosphorylation of
Cep55 may allow it to relocate to the centrosome upon
entry into G1.
Fluctuations in the activity of Cdks drive cells to pro-
gress through mitosis. Specifically, mitotic entry is pro-
moted by elevated activity of Cdk1 when complexed
with cyclin B1 (Pines, 1995), while the exit from mitosis
requires the inactivation of Cdk1 (Zachariae and Na-
smyth, 1999) and the dephosphorylation of at least a
subset of Cdk1 substrates (Visintin et al., 1998). We de-
monstrate that Cep55 is phosphorylated at S425 and
S428 by Cdk1/cyclin B1 upon mitotic entry, which is
when this kinase is found at the centrosome. Another
kinase, Erk2, has recently been shown to also localize
to the mitotic centrosomes (Lou et al., 2004). We il-
lustrate that S425 and S428 can also be phosphory-
lated by Erk2 upon mitotic entry. In addition to Cdk1
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pnd Erk2, we demonstrate that Cep55 is also phos-
horylated by Plk1 and this phosphorylation event is
ependent on prior phosphorylation by Cdk1 and/or
rk2 at S425 and S428. Plk1 locates to the midbody
nd its role during cytokinesis has been demonstrated
n yeast, Drosophila, and mammals. Our data strongly
ndicate that Cep55 and Plk1 colocalize at the midbody
nd that Plk1-dependent phosphorylation of Cep55 is
equired for completion of cytokinesis. In addition, the
lk1-dependent phosphorylation mutant S436A causes
ytokinesis failure to the same extent as the Cdk1/
rk2-dependent mutant S425/428A, indicating that
hosphorylation at S436 is absolutely required for the
unction of Cep55 during cytokinesis, whereas phos-
horylation at S425 and S428 is not required for Cep55
ytokinesis function directly but is essential for Plk1-
ependent phosphorylation at S436. These findings in-
icate that Cep55 and Plk1 may cooperate at the mid-
ody to coordinate mitotic exit and cytokinesis. Thus,
e propose that unphosphorylatable Cep55 may fail to
ind or generate the required signal to downstream
omponents of the mitotic exit pathway.
Cep55 was found to localize to the centrosome via
ts C-terminus and this same region was shown to as-
ociate in vivo with the centrosome proteins CG-NAP
nd Kendrin. In contrast to CG-NAP and Kendrin, which
ain affinity for the centrosome to participate in γ-TuRC
nchorage (Takahashi et al., 2002), we show that Cep55
oses affinity for the centrosome upon mitotic entry co-
nciding with its dissociation from CG-NAP and Ken-
rin. Thus, it is not surprising that we find no require-
ent of Cep55 for microtubule nucleation. Loss of
ep55 from the centrosome coincides with its phos-
horylation at the C-terminal residues S425 and S428.
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by either Erk2 or Cdk1 causes a conformational change
in the protein causing it to lose affinity for CG-NAP and
Kendrin, consequently becoming displaced from the
centrosome at the G2/M boundary. This in turn may en-
able S436 of Cep55 to be accessible to Plk1 for phos-
phorylation. We hypothesize that the displacement of
Cep55 from the centrosome enables CG-NAP and Ken-
drin to strongly anchor themselves to the centrosome
by binding calmodulin (Takahashi et al., 2002). Consis-
tent with this idea, Cep55 and calmodulin bind the
same region of CG-NAP, and the CG-NAP/Kendrin/cal-
modulin interaction is thought to occur only during mi-
tosis, which is when calmodulin is observed at the cen-
trosome (Li et al., 1999).
Increased centrosome number and abnormal centro-
some morphology have been described in many human
tumors (D’Assoro et al., 2002). Therefore, it is not sur-
prising that abnormal expression of many centrosome
proteins, such as Aurora A kinase (Ewart-Toland et al.,
2003), has been linked with different stages of cancer
progression, particularly high cytological grade. Cen-
trosomes act as dominant microtubule nucleating sites,
and when multiple centrosomes are present they give
rise to multiple spindle poles during metaphase, which
in turn leads to aberrant divisions and increased ge-
netic instability (Doxsey, 2002). We show that Cep55-
depleted cells undergo cytokinesis failure inducing an-
euploidy and multiple spindle poles. This event could
generate genomic instability and thus facilitate the loss
of tumor suppressor genes and activation of onco-
genes. Furthermore, the overexpression of Cep55 also
induces aneuploidy, albeit to a lesser extent than
Cep55 depletion. Nevertheless, these data suggest that
the expression of Cep55 must be tightly regulated to
ensure that the final stages of cell division occur cor-
rectly. Therefore, it will be interesting to determine
whether the expression and phosphorylation of Cep55
is altered in cancer cells.
Experimental Procedures
Cell Culture and Transfection
293T, Cos-7, and HeLa cells were maintained in RPMI 1640 medium
supplemented with 10% fetal calf serum and grown at 37°C in a
humidified 5% CO2 atmosphere. For immunoblotting experiments,
cells were seeded at 50%–60% confluence/10 cm2 dish and trans-
fected with 7.5 g of plasmid DNA using Lipofectamine 2000 (Invit-
rogen, Carlsbad, CA) according to the manufacturer’s instructions.
Alternatively, cells (5 × 106) were transfected by electroporation
with 7.5 g of plasmid DNA, and then seeded onto 10 cm2 dishes.
For immunofluorescence experiments, cells were seeded onto cov-
erslips and transfected at 50%–60% confluence with 1.5 g of
plasmid DNA with Lipofectamine 2000. Where indicated, to inhibit
phosphatase activity, asynchronous cells were treated with the ser-
ine/threonine phosphatase inhibitor okadaic acid (10 M) for 16 hr.
Cell Synchronization and Flow Cytometry
Cells were synchronized by double-thymidine block and collected
at the G1/S border (0 hr), S phase (4 hr), G2 phase (8 hr), and mitosis
(10 hr). At each time point, cells were processed for immunoblot-
ting and for FACS analysis as previously described (Fabbro et al.,
2004). For mitotic synchronization of cells, cells were treated with
0.5 g/ml nocodazole for 16 hr. Mitotic arrested cells were col-
lected by “mitotic shake-off.” To inhibit Cdk1 activity, after nocoda-
zole treatment (16 hr), roscovitine (55 M) was added for 4 hr. To
inhibit Erk2 activity, cells were treated with 0.5 g/ml nocodazoleand 10 M U0126 for 16 hr. To ensure a mitotic arrest, these cells
were also treated with 10 g/ml ALLN, a proteasome inhibitor, be-
cause it has been suggested that cells can escape nocodazole-
induced arrest in the presence of U0126 (Chung and Chen, 2003).
Immunoprecipitation and Immunoblotting
Cellular extracts were prepared as described previously (Fabbro et
al., 2004). Where indicated, cell lysates were treated with lambda
phosphatase (λ-PPase; New England Biolabs, Ipswich, MA) for 30
min at 30°C. For Plk1/Cep55 coimmunoprecipitation experiments,
protein samples precleared with protein G beads were incubated
with the required antibody for 2 hr. Immune complexes were col-
lected with protein G-Sepharose beads, washed twice with lysis
buffer, and then fractionated by SDS-PAGE for immunoblot analy-
sis. For CG-NAP/Kendrin/Cep55, coimmunoprecipitation experi-
ments were performed as described previously (Takahashi et al.,
2002). The following primary antibodies were used for immunoblot-
ting: anti-Cep55, anti-γ-tubulin (T5192; Sigma, St. Louis, MO), anti-
Flag M2 (Sigma), anti-Myc (Cell Signaling, Beverly, MA), anti-GFP
(Molecular Probes, Eugene, OR), anti-Plk1 (37-7000; Zymed, San
Francisco, CA), and anti-Cdk1 (De Souza et al., 2000). Primary anti-
body bound to the indicated protein was detected by incubation
with a horseradish peroxidase-conjugated secondary antibody
(Sigma). Blotted proteins were visualized using the ECL detection
system (Amersham, Piscataway, NJ).
Immunofluorescence and Confocal Microscopy
Cells were fixed in ice-cold methanol for 10 min at −20°C, washed
three times with PBS, and then blocked in 3% bovine serum albu-
min/PBS for 45 min before the required primary antibody was ap-
plied. The following antibodies were used: anti-Cep55, anti-α-tubu-
lin (clone DM1A; Sigma), anti-γ-tubulin (GTU88; Sigma), GT335,
anti-CG-NAP, and anti-Kendrin (Takahashi et al., 2002), anti-Plk1
(37-7000; Zymed), and anti-centriolin (Gromley et al., 2003). Cells
were then washed with PBS and incubated with Alexa 488- or
Alexa 546-conjugated secondary antibody (Molecular Probes). Cell
nuclei were counterstained with Hoechst 33285 (Sigma). After
extensive washing, coverslips were mounted onto glass micro-
scope slides with Mowiol and cells were viewed with a fluores-
cence microscope (Zeiss, Jena, Germany). Fluorescence and dif-
ferential interference contrast (DIC) images were captured and
processed using a Leica (Bernsheim, Germany) DMIRB/E confocal
microscope.
In Vivo Microtubule Nucleation Assay
Cells were placed on ice for 30 min to depolymerize microtubules.
The cold medium was aspirated and medium prewarmed to 37°C
was added for 2 min. Cells were washed twice with PBS, and then
permeabilized in 80 mM K-PIPES (pH 6.8), 1 mM EGTA, 1 mM
MgCl2, 0.1% Triton X-100 for 45 s. Cells were washed three times
with PBS and then fixed in ice-cold methanol for 10 min at −20°C
before being processed for immunofluorescence microscopy to vi-
sualize microtubules by staining for α-tubulin.
Supplemental Data
Plasmid construction, Northern blotting, in vitro kinase assays,
in vivo 32P labeling, phosphoamino acid analysis, mass spec-
trometry, and time-lapse microscopy are available at http://www.
developmentalcell.com/cgi/content/full/9/4/477/DC1/.
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